Comparative effectiveness of centesimal and 50 millesimal potencies in treatment of atopic dermatitis in adults: An open, randomized trial

D N De Homoeopathic Medical College Hospital0 个研究点目标入组 0 人开始时间: 待定最近更新: 2022年10月17日

试验速览

暂无简介。

•1. Newly diagnosed cases of AD (ICD-10-CM code L20.9) as per UK diagnostic criteria with a minimum duration of suffering of 3 months
•2. PO-SCORAD values more than 10
•3. Age: 18-65 years
•4. Participants of either sex
•5. Literate patients; ability to read Bengali and/or English
•6. Patients giving written informed consent to participate
•7. Patients already undergoing treatment for AD were planned to be recruited on completely stopping the medicines and after wash-out phase of 1 month

•1. Severe and disseminated forms of atopic dermatitis
•2. Vulnerable population Ã¢â?¬â?? unconscious, ambulatory, too sick for consultation, differently abled, terminally ill or critically ill patients, institutionalized subjects, mentally incompetent people
•3. Diagnosed cases of unstable psychiatric or uncontrolled or life-threatening systemic illness affecting quality of life or any organ failure
•4. Tobacco chewing and/or smoking or any other form(s) of substance abuse and/or dependence
•5. Self-reported immune-compromised states
•6. Pregnant and lactating women, puerperal mothers
•7. Patients already undergoing homeopathic treatment for any chronic disease within last 6 months

发起方